{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,25]],"date-time":"2024-08-25T00:40:41Z","timestamp":1724546441369},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,2,27]],"date-time":"2008-02-27T00:00:00Z","timestamp":1204070400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1007\/s00774-007-0807-3","type":"journal-article","created":{"date-parts":[[2008,2,26]],"date-time":"2008-02-26T18:41:57Z","timestamp":1204051317000},"page":"178-184","source":"Crossref","is-referenced-by-count":6,"title":["Three-month changes in bone turnover markers and bone mineral density response to raloxifene in Japanese postmenopausal women with osteoporosis"],"prefix":"10.1007","volume":"26","author":[{"given":"Takafumi","family":"Majima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Shimatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasato","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Fukao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Ninomiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuwa","family":"Nakao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,2,27]]},"reference":[{"key":"807_CR1","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00198-003-1424-1","volume":"14","author":"H. Morii","year":"2003","unstructured":"Morii H, Ohashi Y, Taketani Y, Fukunaga M, Nakamura T, Itabashi A, Sarkar S, Harper K (2003) Effect of raloxifene on bone mineral density and biochemical markers of bone turnover in Japanese postmenopausal women with osteoporosis: results from a randomized placebo-controlled trial. Osteoporos Int 14:793\u2013800","journal-title":"Osteoporos Int"},{"key":"807_CR2","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s00774-006-0702-3","volume":"24","author":"T. Nakamura","year":"2006","unstructured":"Nakamura T, Liu JL, Morii H, Huang QR, Zhu HM, Qu Y, Hamaya E, Thiebaud D (2006) Effect of raloxifene on clinical fractures in Asian women with postmenopausal osteoporosis. J Bone Miner Metab 24:414\u2013418","journal-title":"J Bone Miner Metab"},{"key":"807_CR3","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","volume":"282","author":"B. Ettinger","year":"1999","unstructured":"Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, et al (1999) Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA 282:637\u2013645","journal-title":"JAMA"},{"key":"807_CR4","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s00774-006-0738-4","volume":"25","author":"T. Fujita","year":"2007","unstructured":"Fujita T, Orimo H, Inoue T, Kaneda K, Sakurai M, Morita R, Yamamoto K, Sugioka Y, Inoue A, Takaoka K, Yamamoto I, Hoshino Y, Kawaguchi H (2007) Clinical effect of bisphosphonate and vitamin D on osteoporosis: reappraisal of a multicenter double-blind clinical trial comparing etidronate and alfacalcidol. J Bone Miner Metab 25:130\u2013137","journal-title":"J Bone Miner Metab"},{"key":"807_CR5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00774-005-0639-y","volume":"24","author":"H. Mizunuma","year":"2006","unstructured":"Mizunuma H, Shiraki M, Shintani M, Gorai I, Makita K, Itoga S, Mochizuki Y, Mogi H, Iwaoki Y, Kosha S, Yasui T, Ishihara O, Kurabayashi T, Kasuga Y, Hayashi K (2006) Randomized trial comparing low-dose hormone replacement therapy and HRT plus 1-alpha-OH-vitamin D3 (alfacalcidol) for treatment of postmenopausal bone loss. J Bone Miner Metab 24:11\u201315","journal-title":"J Bone Miner Metab"},{"key":"807_CR6","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s00774-004-0508-0","volume":"22","author":"K. Kushida","year":"2004","unstructured":"Kushida K, Shiraki M, Nakamura T, Kishimoto H, Morii H, Yamamoto K, Kaneda K, Fukunaga M, Inoue T, Nakashima M, Orimo H (2004) Alendronate reduced vertebral fracture risk in postmenopausal Japanese women with osteoporosis: a 3-year follow-up study. J Bone Miner Metab 22:462\u2013468","journal-title":"J Bone Miner Metab"},{"key":"807_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1359\/jbmr.2002.17.1.1","volume":"17","author":"S. Sarkar","year":"2002","unstructured":"Sarkar S, Mitlak BH, Wong M, Stock JL, Black DM, Harper KD (2002) Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy. J Bone Miner Res 17:1\u201310","journal-title":"J Bone Miner Res"},{"key":"807_CR8","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1359\/JBMR.0301243","volume":"19","author":"S. Sarkar","year":"2004","unstructured":"Sarkar S, Reginster JY, Crans GG, Diez-Perez A, Pinette KV, Delmas PD (2004) Relationship between changes in biochemical markers of bone turnover and BMD to predict vertebral fracture risk. J Bone Miner Res 19:394\u2013401","journal-title":"J Bone Miner Res"},{"key":"807_CR9","doi-asserted-by":"crossref","first-page":"676","DOI":"10.3349\/ymj.2004.45.4.676","volume":"45","author":"J. Iwamoto","year":"2004","unstructured":"Iwamoto J, Takeda T, Sato Y, Uzawa M (2004) Determinants of one-year response of lumbar bone mineral density to alendronate treatment in elderly Japanese women with osteoporosis. Yonsei Med J 45:676\u2013682","journal-title":"Yonsei Med J"},{"key":"807_CR10","first-page":"1693","volume":"79","author":"P. Garnero","year":"1994","unstructured":"Garnero P, Shih WJ, Gineyts E, Karpf DB, Delmas PD (1994) Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrinol Metab 79:1693\u20131700","journal-title":"J Clin Endocrinol Metab"},{"key":"807_CR11","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1359\/jbmr.1998.13.9.1431","volume":"13","author":"S.L. Greenspan","year":"1998","unstructured":"Greenspan SL, Parker RA, Ferguson L, Rosen HN, Maitland-Ramsey L, Karpf DB (1998) Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial. J Bone Miner Res 13:1431\u20131438","journal-title":"J Bone Miner Res"},{"key":"807_CR12","first-page":"2363","volume":"84","author":"P. Ravn","year":"1999","unstructured":"Ravn P, Hosking D, Thompson D, Cizza G, Wasnich RD, McClung M, Yates AJ, Bjarnason NH, Christiansen C (1999) Monitoring of alendronate treatment and prediction of effect on bone mass by biochemical markers in the early postmenopausal intervention cohort study. J Clin Endocrinol Metab 84:2363\u20132368","journal-title":"J Clin Endocrinol Metab"},{"key":"807_CR13","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1507\/endocrj.52.667","volume":"52","author":"S.W. Kim","year":"2005","unstructured":"Kim SW, Park DJ, Park KS, Kim SY, Cho BY, Lee HK, Shin CS (2005) Early changes in biochemical markers of bone turnover predict bone mineral density response to antiresorptive therapy in Korean postmenopausal women with osteoporosis. Endocr J 52:667\u2013674","journal-title":"Endocr J"},{"key":"807_CR14","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1359\/jbmr.2003.18.6.1051","volume":"18","author":"R. Eastell","year":"2003","unstructured":"Eastell R, Barton I, Hannon RA, Chines A, Garnero P, Delmas PD (2003) Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate. J Bone Miner Res 18:1051\u20131056","journal-title":"J Bone Miner Res"},{"key":"807_CR15","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1359\/JBMR.040512","volume":"19","author":"D.C. Bauer","year":"2004","unstructured":"Bauer DC, Black DM, Garnero P, Hochberg M, Ott S, Orloff J, Thompson DE, Ewing SK, Delmas PD (2004) Change in bone turnover and hip, nonspine, and vertebral fracture in alendronatetreated women: the fracture intervention trial. J Bone Miner Res 19:1250\u20131258","journal-title":"J Bone Miner Res"},{"key":"807_CR16","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1172\/JCI113725","volume":"82","author":"R. Civitelli","year":"1988","unstructured":"Civitelli R, Gonelli S, Sachei F (1988) Bone turnover in postmenopausal osteoporosis: effect of calcitonin treatment. J Clin Invest 82:1268\u20131274","journal-title":"J Clin Invest"},{"key":"807_CR17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0002-9343(96)00387-7","volume":"20","author":"C. Chesnut","year":"1997","unstructured":"Chesnut C, Bell N, Clark G, Drinkwater B, English S, Johnson CJ, Notelovitz M, Rosen C, Cain D, Flessland K, Mallinak N (1997) Hormone replacement therapy in postmenopausal women: urinary N-telopeptide of type I collagen monitors therapeutic effect and predicts response of bone mineral density. Am J Med 20: 29\u201337","journal-title":"Am J Med"},{"key":"807_CR18","first-page":"1904","volume":"82","author":"C.J. Rosen","year":"1997","unstructured":"Rosen CJ, Chesnut CH III, Mallinak NJS (1997) The predictive value of biochemical markers of bone turnover for bone mineral density in early postmenopausal women treated with hormone replacement or calcium supplementation. J Clin Endocrinol Metab 82:1904\u20131910","journal-title":"J Clin Endocrinol Metab"},{"key":"807_CR19","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1007\/s001980170020","volume":"12","author":"N.H. Bjarnason","year":"2001","unstructured":"Bjarnason NH, Sarkar S, Duong T, Mitlak B, Delmas PD, Christiansen C (2001) Six and twelve month changes in bone turnover are related to reduction in vertebral fracture risk during 3 years of raloxifene treatment in postmenopausal osteoporosis. Osteoporos Int 12:922\u2013930","journal-title":"Osteoporos Int"},{"key":"807_CR20","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s007740170001","volume":"19","author":"H. Orimo","year":"2001","unstructured":"Orimo H, Hayashi Y, Fukunaga M, Sone T, Fujiwara S, Shiraki M, Kushida K, Miyamoto S, Soen S, Nishimura J, Oh-Hashi Y, Hosoi T, Gorai I, Tanaka H, Igai T, Kishimoto H; Osteoporosis Diagnostic Criteria Review Committee: Japanese Society for Bone and Mineral Research (2001) Diagnostic criteria for primary osteoporosis: year 2000 revision. J Bone Miner Metab 19:331\u2013337","journal-title":"J Bone Miner Metab"},{"key":"807_CR21","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1359\/jbmr.2000.15.7.1398","volume":"15","author":"A. Rogers","year":"2000","unstructured":"Rogers A, Hannon RA, Eastell R (2000) Biochemical markers as predictors of rates of bone loss after menopause. J Bone Miner Res 15:1398\u20131404","journal-title":"J Bone Miner Res"},{"key":"807_CR22","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1359\/JBMR.050509","volume":"20","author":"E.S. Siris","year":"2005","unstructured":"Siris ES, Harris ST, Eastell R, Zanchetta JR, Goemaere S, Diez-Perez A, Stock JL, Song J, Qu Y, Kulkarni PM, Siddhanti SR, Wong M, Cummings SR; Continuing Outcomes Relevant to Evista (CORE) Investigators (2005) Skeletal effects of raloxifene after 8 years: results from the continuing outcomes relevant to Evista (CORE) study. J Bone Miner Res 20:1514\u20131524","journal-title":"J Bone Miner Res"},{"key":"807_CR23","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1210\/jcem.87.3.8325","volume":"87","author":"O. Johnell","year":"2002","unstructured":"Johnell O, Scheele WH, Lu Y, Reginster JY, Need AG, Seeman E (2002) Additive effects of raloxifene and alendronate on bone density and biochemical markers of bone remodeling in postmenopausal women with osteoporosis. J Clin Endocrinol Metab 87: 985\u2013992","journal-title":"J Clin Endocrinol Metab"},{"key":"807_CR24","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/1529-0131(199906)42:6<1246::AID-ANR22>3.0.CO;2-U","volume":"42","author":"M.C. Hochberg","year":"1999","unstructured":"Hochberg MC, Ross PD, Black D, Cummings SR, Genant HK, Nevitt MC, Barrett-Connor E, Musliner T, Thompson D (1999) Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis. Fracture Intervention Trial Research Group. Arthritis Rheum 42:1246\u20131254","journal-title":"Arthritis Rheum"},{"key":"807_CR25","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1507\/endocrj.52.161","volume":"52","author":"M. Ohmichi","year":"2005","unstructured":"Ohmichi M, Tasaka K, Kurachi H, Murata Y (2005) Molecular mechanism of action of selective estrogen receptor modulator in target tissues. Endocr J 52:161\u2013167","journal-title":"Endocr J"},{"key":"807_CR26","first-page":"3425","volume":"82","author":"R.P. Heaney","year":"1997","unstructured":"Heaney RP, Draper MW (1997) Raloxifene and estrogen: comparative bone-remodeling kinetics. J Clin Endocrinol Metab. 82: 3425\u20133429","journal-title":"J Clin Endocrinol Metab."}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-007-0807-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00774-007-0807-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-007-0807-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T06:14:20Z","timestamp":1559110460000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00774-007-0807-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,27]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["807"],"URL":"https:\/\/doi.org\/10.1007\/s00774-007-0807-3","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,27]]}}}